|
CPEX Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company in
the business of development, licensing and commercialization of pharmaceutical
products utilizing our validated drug delivery technology. Our technology enhances
permeation and absorption of pharmaceutical molecules across the skin, nasal mucosa
and eye through formulation development with proprietary molecules such as CPE-215®.
We have licensed an application of our drug delivery technology to Auxilium
Pharmaceuticals, which led to the launch of Testim® in the United States in February
2003, the first product incorporating our technology.
Our research and development program is primarily focused on the development of
Nasulin, our intranasal insulin product candidate. Nasulin, which is in Phase 2
clinical development, is our patented intranasal insulin spray which incorporates
CPE-215 as a permeation facilitator that addresses the need for an insulin product
that more closely resembles the body’s normal physiological response and provides a
more patient-friendly delivery method. We believe these potential benefits could
reshape the insulin market. |
